University of Texas financial grant in support of cancer research and treatment
University of Texas financial grant in support of cancer research and treatment
The Khalifa Foundation and the University of Texas signed an agreement under which the Foundation will provide the University with a financial grant of $ 150 million in support of research, diagnosis and treatment of cancerous diseases through the results of genetic analysis.The grant finances the construction of the Sheikh Zayed bin Sultan Cancer Center attached to the University Hospital on an area of ​​600,000 square feet, which includes the Sheikh Khalifa bin Zayed Al Nahyan Institute for Specialized Cancer Treatment and the Ahmed bin Zayed Al Nahyan Center for the Treatment of Pancreatic Cancer .. While the grant finances the establishment of a fund My endowment is to finance three professorships bearing the name of the late Sheikh Zayed bin Sultan Al Nahyan, the first chair is devoted to medical oncology, the second chair is allocated to the Sheikh Khalifa bin Zayed University fund for specialized knowledge in the fields of cancer, and the third chair in the name of His Highness Sheikh Mohammed bin Zayed Al Nahyan for scientific and medical knowledge specialized in research Cancer..in addition to the grant funding, a number of specialized fellowships are annually.For his part, the price of Francisco J. Cigarwa, President of the University of Texas, following the signing of the agreement, honored the Khalifa Foundation for Humanitarian Work, noting that it is an embodiment of charitable work that has become a feature associated with the name of the United Arab Emirates .. To humanity.For his part, John Mendelson, head of the MD Anderson Cancer Center at the University of Texas, affirmed that the scholarship is the largest grant offered to the center and the largest for the university, extending great thanks and gratitude to the awarding institution on behalf of cancer patients and their caregivers around the world for this The generous grant that will be devoted to support efforts exerted to implement new, more effective treatments.In his statement on this occasion, Mendelssohn announced his resignation from his position to devote himself to the management of the Khalifa bin Zayed Al Nahyan Institute for the Treatment of Cancer Diseases, noting that a group of doctors, scientists and researchers will join the center's family to participate in their efforts in the research of studying and identifying the causes of the genetic and molecular defects that cause cancer for each patient separately. Develop treatment options and medical care for each case.He added that the generous grant supports the center’s efforts to enable it to increase the programs devoted to developing partial pathology, leading to the diagnosis of cancer for each patient separately, by accurately identifying the genetic defects and the treatment required.